Hunter Biden, Second Amendment Warrior?

President Joe Biden has long been an advocate for strict restrictions on guns, so his son makes something of an unlikely advocate for expanded gun rights. But Hunter Biden may soon find himself on the opposite side of his father’s gun control crusade in at least one aspect. The younger Biden is reportedly considering a challenge to a federal law that bans illegal drug users from owning guns.

The issue hits close to home for Hunter: The Department of Justice is investigating a gun purchase he made in 2018. This is a time period during which he has admitted to regularly using crack cocaine. That could put him afoul of the law against drug users having guns.

Hunter Biden’s “lawyers have already told Justice Department officials that, if their client is charged with the gun crime, they will challenge the law under the Second Amendment, according to a person familiar with the private discussions granted anonymity because they are not authorized to speak publicly,” reported Politico. “That could turn a case that is already fraught with political consequences into a high-profile showdown over the right to bear arms.”

Here’s hoping?

The provision in question—part of the Gun Control Act of 1968—is, frankly, insane, preventing any person “who is an unlawful user of or addicted to any controlled substance” from buying a gun. The Bureau of Alcohol, Tobacco, and Firearms has interpreted this provision to mean that anyone who has used any illegal drug in the past 12 months cannot legally purchase a gun.

And the time may be just right for challenging it. This Supreme Court has proved willing to strike down overreaching gun laws.

Keep reading

ATF: Marijuana users in Minnesota can’t own firearms despite new law

Just one day after Minnesota legalized the recreational use of marijuana, an agency that regulates the use of firearms warned that any current user of marijuana is prohibited from possessing firearms or ammunition.  

The Bureau of Alcohol, Tobacco, Firearms and Explosives (AFT) field office in St. Paul, Minn., issued the clarification Tuesday shortly after Gov. Tim Walz (D) signed a bill legalizing recreational marijuana. The clarification states that under federal law, current users of marijuana are prohibited from possessing, receiving, transporting or shipping firearms or ammunition.  

“Until marijuana is legalized federally, firearms owners and possessors should be mindful that it remains federally illegal to mix marijuana with firearms and ammunition,” Jeff Reed, ATF’s acting special agent in charge of the St. Paul Field Division, said in a statement.

“As regulators of the firearms industry and enforcers of firearms laws, we felt it was important to remind Minnesotans of this distinction as the marijuana laws adjust here in the State of Minnesota.” 

According to an analysis by the RAND Corporation, nearly 40 percent of residents in Minnesota reported owning a gun between 2007 and 2016. According to the Centers for Disease Control and Prevention, about 18 percent of Americans reported using marijuana in 2019.

Keep reading

L.A. County Gives Crack Pipes to Homeless to Prevent Fentanyl Deaths

Los Angeles County has begun distributing pipes used for smoking crack, methamphetamine, and opioids to the homeless population, hoping to discourage them from overdosing by injecting themselves with fentanyl.

The Los Angeles Times reported on the grim phenomenon Tuesday, which has divided homeless advocates:

By a line of ragged RVs slung along 78th Street in South Los Angeles, a seven-member team passes out glass pipes used for smoking opioids, crack and methamphetamine.

Part of the front line of Los Angeles County’s offensive against the deadly fentanyl epidemic, the group hands out other supplies: clean needles, sanitary wipes, fentanyl test strips and naloxone, medication that can reverse an overdose.

Fentanyl, which is laced in everything from weed to heroin and meth, was present in more than half of the nearly 1,500 overdose deaths of homeless people in 2020-21. In response, Los Angeles County this year increased its harm reduction budget from $5.4 million to $31.5 million. Most of the money covers staffing and programs; officials said that only a fraction of county funds — no state or federal money— goes to pipes.

Some believe that the pipes merely facilitate addiction; others argue that they slow the rate of drug intake.

Keep reading

Psychedelic substance 5-MeO-DMT induces long-lasting neural plasticity in mice

The psychedelic substances 5-MeO-DMT causes a long-lasting increase in the number of tiny protrusions called dendritic spines in the brain, according to new research published in Neuropsychopharmacology. The study, which was conducted on mice, sheds light on the behavioral and neural mechanisms of 5-MeO-DMT.

Serotonergic psychedelics (such as psilocybin and LSD) have shown promise as potential therapeutics for mental illnesses like depression and anxiety. Short-acting compounds are particularly interesting because they require less dosing time, which could improve patient access to treatment. In humans, 5-MeO-DMT produces a short-lasting experience due to its rapid breakdown in the body.

“My lab started research on psychiatric drugs like ketamine and psychedelics about 10 years ago. We were motivated by how basic science and clinical research can together powerfully move a drug forward to become medicine. Specifically I believe there is a lot of potential for psychedelics as therapeutics, and that drives our interest in this topic,” said study author Alex Kwan (@kwanalexc), an associate professor in the Meinig School of Biomedical Engineering at Cornell University.

5-MeO-DMT, found in the Sonoran Desert toad, has some unique pharmacological properties. It targets serotonin receptors, specifically the 5-HT1A and 5-HT2A subtypes, similar to psilocybin but with a higher affinity for 5-HT1A receptors. However, little is known about the long-term effects of 5-MeO-DMT. To address this, the researchers conducted a study using mice.

Keep reading

U.S. Faces Massive Shortage Of Prescription Drugs

Record drug shortages across the United States are delaying potentially lifesaving treatments for thousands of patients around the country.

Congress and the White House are scrambling to address a shortfall in prescription drugs — everything from painkillers to cancer treatments. 

“Hospitals all across the country, on a regular basis –sometimes weekly — have to review which drugs are in short supply or not available that week.” Senator Gary Peters (D-MI) said in an interview with MSNBC.

The shortage is being most acutely felt in the generic drug market, which accounts for nearly 90% of U.S. prescriptions. The exact number of drugs being affected depends on who you ask — according to a Senate report at the end of last year, the U.S. reached a peak level of 295 active drug shortages, although as of March, the FDA claims there are 130. The American Society of Health reports 301 drug shortages as of the first quarter of 2023.

According to the FDA, the average drug shortage lasts for about 18 months, but some shortages have stretched on for over 15 years.

Some of the medicines that have been in short supply include Adderall, Tylenol, various antibiotics including amoxicillin, saline mixtures used in IVs, and almost two dozen kinds of anti-cancer drugs.

That last group is especially troubling because, unlike some other drugs in short supply, patients don’t have a lot of alternate options for treatment. Chemotherapies for breast cancers, ovarian cancers, lung cancers, bladder cancers, and some forms of leukemia have been delayed or disrupted, sometimes with fatal consequences.

Keep reading

CIA Officers Admit the Agency Ran Drug Trafficking Operations

In 1991, during the 1st Persian Gulf War, investigative journalist Douglas Valentine traveled to Thailand and interviewed a group of legendary CIA officers who had helped run the secret war in Laos and other clandestine operations in the Indochina Wars.

Among them was Anthony Poshepny (aka Tony Poe), the prototype for Colonel Kurtz in Francis Ford Coppola’s epic 1979 film Apocalypse Now—a covert warrior who went off the deep end and established a secret jungle enclave where enemy body parts were displayed.[1]

Now 66, Poshepny lived at the time in a big, beautiful home in a fancy neighborhood in Udon Thani, Thailand, home of a major U.S. air base during the Indochina Wars used for carrying out secret bombing missions over Laos.

Poshepny owned a lumber and security consultant business and a sugar and tapioca farm; he was considered around town to be a friendly guy but a belligerent drunk.

Poshepny’s father had been a naval officer and he had become desensitized to violence serving with the Marines in the Battle of Iwo Jima during World War II.

During a meeting with Poshepny, who suffered from diabetes and cirrhosis from years of heavy drinking, Valentine noticed that he was missing two middle fingers. Poshepny also liked to tell obscene jokes.

He told Valentine that he was proud of things he had done with political implications, notably his involvement in a failed CIA coup against Indonesian socialist leader Sukarno in 1958, where he and CIA officer “Pat” Landry supplied mutinous military forces in oil-rich Sumatra with M16s and thousands of rounds of ammunition. “It was an adventure,” Poshepny said.

Keep reading

More than 90% of Calif. pot farms infected with ‘severe’ pathogen

An infectious pathogen inside California’s pot farms is attacking cannabis plants and growing invisibly for months only to spoil a crop just as a farmer is ready to harvest. Scientists believe that it’s in nearly every pot farm in the state and could be causing billions of dollars in damages to the national weed economy.

Hop-latent viroid, or HLVd, shrivels pot plants and reduce how much weight they produce by as much as 30%. It also destroys the amount of THC, pot’s most common active compound, that a plant produces, greatly reducing the value of affected plants. 

HLVd was first documented in cannabis in a pair of scientific studies published in 2019, including a study that confirmed the viroid’s presence in samples from a Santa Barbara pot farm. It’s now infected at least 90% of California’s cannabis grows, according to a 2021 estimate. It’s spreading globally, and a recent scientific paper declared the pathogen was the “biggest concern for cannabis” growers worldwide.

But one Bay Area startup has a new tool that they think will stop the pathogen’s spread in its tracks.

Oakland’s Purple City Labs released a new HLVd test earlier this year that can be conducted on site and deliver results to pot farmers in just a few hours. That’s much faster than the current methods for finding HLVd infections, which are predominantly done by farmers mailing samples to labs and waiting days or even weeks to get a result.

The company said this new at-farm testing could be pivotal in slowing the spread of this global pathogen, as it allows farmers to quickly identify infected plants.

“We didn’t just identify a great test that is accurate, but it’s [also] easy to use and it doesn’t require a high level of expertise,” said Luke Horst, director of business development for Purple City Genetics. “You can take microbiology to the public and put it in their hands. … It’s important for people to have this type of testing.”

Keep reading

DRUG WAR TACTICS WON’T STOP XYLAZINE DEATHS

Over the past six months, national and local media have flooded the news cycle with stories about the “horrors” of xylazine, a non-opioid animal tranquilizer increasingly found mixed with fentanyl, sometimes to deadly effect. Outlets including the New York Times and CNN have trafficked in graphic portrayals of xylazine use, even calling it “the zombie drug,” a term advocates say fuels stigma and punitive measures against people who use drugs.

Indeed, amid this wave of sensationalized coverage and broader concerns that xylazine is driving up overdose rates nationwide, lawmakers have responded by rushing to criminalize possession of the drug. But critics fear the current push against xylazine is repeating the cycle that led to its rise.

Four states, FloridaWest VirginiaOhio, and Pennsylvania, have already added xylazine to their lists of controlled substances. Proposed legislation in the U.S. House of Representatives and Senate would criminalize some xylazine possession at the federal level and increase funding for law enforcement to “crack down on its spread,” in the words of one of the bill’s sponsors.

This official response to xylazine mirrors tactics that have been used for decades in campaigns against emerging “drugs of concern.”

Keep reading

The Republican Primary Consensus for Sending the Military Into Mexico

When Sen. Tim Scott (R–S.C.), a comparatively affable chap in the context of contemporary GOP politics, announced his 2024 presidential bid on Monday, the speech was predictably full of the upbeat, anecdotal, ain’t-America-grand stuff that Scott, like generations of Republicans before him, has made central to his political career.

Then things suddenly turned dark.

“When I am president, the drug cartels using Chinese labs and Mexican factories to kill Americans will cease to exist,” Scott vowed. “I will freeze their assets, I will build the wall, and I will allow the world’s greatest military to fight these terrorists. Because that’s exactly what they are.”

Scott’s bellicosity was no mere bolt from the blue. As Reason has been documenting for six years now, Republicans, even while otherwise souring on U.S interventionism abroad, have increasingly concluded that the alarming spike in domestic fentanyl overdoses would best be treated by sending the military into Mexico.

Donald Trump first floated the idea, while he was president, of designating drug cartels as terrorist organizations—thereby allowing for extraterritorial prosecutions, enhanced investigative powers, and increased penalties for domestic drug-related crimes—in March 2019, but held off after the government of Mexico repeatedly objected on grounds of sovereignty while making uncooperative noises about transnational migration policy.

But the appetite for corralling cartels into the otherwise-unpopular war on terror was only beginning to rumble in the conservative belly. Trump himself in the summer of 2020 twice asked then–Defense Secretary Mark Esper whether “we could just shoot some Patriot missiles and take out the labs, quietly,” according to Esper’s 2022 memoir. Notable MAGA politicians Sen. J.D. Vance (R–Ohio) and Rep. Marjorie Taylor Greene (R–Ga.) have both suggested violent interdiction south of the border, as have a bevy of more traditional hawks. There are a handful of escalatory bills bouncing around Congress.

Keep reading

Taxpayers May Soon Be Filling the Funding Gaps in Oregon’s Psilocybin System

So far, just three psilocybin service centers—offices where people can go on legal mushroom trips—have been licensed by the state of Oregon.

That’s bad news for law-abiding people itching to avail themselves of the much-advertised benefits of psilocybin: relief from depression, alcoholism, obsessive-compulsive disorder, and end-of-life dread.

It’s also bad news for taxpayers, who may soon find themselves underwriting a shroom system that was supposed to pay for itself.

Proponents of Measure 109, the initiative that created Oregon’s legal psilocybin program, designed it to be funded by fees, not taxpayer dollars, so it would be palatable to more voters. Service centers, mushroom growers, and psilocybin testing labs are all required to pay $10,000 a year for their licenses. Facilitators, the people who sit with tripping subjects and guide them into the psychosphere, pay $2,000 a year.

The problem is that very few people are getting licenses of any kind to cover the cost of running the Oregon Health Authority’s Psilocybin Services unit, in large part because of the high fees. Very few licensees means very little fee revenue, which means the state has to find cash someplace else to keep the program running.

That other place could be the state’s general fund. OHA has asked for $6.6 million to fill the program’s budget gap for the fiscal biennium starting July 1, according to a 13-page “policy option package,” or POP, that’s now sitting in the Legislature (Salem budgets two years at a time).

“Without the additional funding, the sustainability of the work would be jeopardized,” OHA says in the POP document. “There would be insufficient staff to continue to implement the regulatory program, review license applications and conduct licensure inspections. Consequently, psilocybin businesses seeking licensure could experience financial hardship.”

Keep reading